Success Story: Speedy EB1A Approval! Our Firm Helped a Research Assistant Professor from India Succeed in 18 Days

Client’s Testimonial:

“Working with Chen on my I-140 preparation and filing was truly an outstanding experience. The attention to detail and focused preparation on every component of the petition were exceptional. My attorney and her associates were consistently professional, responsive, and supportive throughout the entire process. Truly appreciate the dedication and efficiency, which made a stressful process feel smooth and manageable. I would always recommend NAmILG for such excellent support!”

On June 14^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Assistant Professor in the Field of Genetic Epidemiology (Approval Notice).

General Field: Genetic Epidemiology

Position at the Time of Case Filing: Research Assistant Professor

Country of Origin: India

State of Residence at the Time of Filing: Michigan

Approval Notice Date: June 14^th, 2025

Processing Time: 18 days (Premium Processing Requested)

Case Summary:

We are proud to share the approval of an I-140 petition under the EB-1A category for a genetic epidemiologist whose influential work has advanced the understanding of disease susceptibility and resistance mechanisms. This approval, secured in just under three weeks, affirms the petitioner’s extraordinary ability and the value of their contributions to global public health and biomedical research.

With a Ph.D. in zoology, the petitioner is recognized for their expertise in identifying causal genes and uncovering dysregulated pathways that drive disease risk. Among the most impactful areas of their research is the study of genetic polymorphisms in the vitamin D receptor (VDR) gene and its association with pulmonary tuberculosis (PTB), including drug-resistant strains. Their pioneering investigations have been foundational for further studies in infectious disease genomics and personalized medicine.

Currently working in academia, the petitioner applies advanced genetics and genomics techniques to understand the genetic architecture of musculoskeletal conditions such as rotator cuff tears and glenohumeral osteoarthritis. This research addresses critical challenges in orthopedic health and is shaping precision treatment strategies in this area.

To demonstrate the petitioner’s extraordinary ability, the I-140 petition emphasized:

● A strong publication record, including 14 peer-reviewed journal articles, 1 preprint, and 1 book chapter,

● A citation count of 219, evidencing significant use and recognition of their work by global peers,

● Over 40 instances of peer review service for top scientific journals and funding agencies, reflecting professional trust in their judgment,

● Ongoing research support from prominent funding bodies across multiple countries, highlighting the sustained international investment in their work.

The petitioner’s research has directly influenced other scientists worldwide, informing studies in genetic risk assessment, disease modeling, and public health interventions. Their publication venues include some of the highest-ranking journals in epidemiology, virology, and musculoskeletal medicine, underscoring the broad relevance and impact of their scholarship.

In addition, two expert letters of recommendation were submitted to USCIS, attesting to the major significance of the petitioner’s contributions. One letter stated:

“Considering the value presented by his tuberculosis (TB) genetic markers, risk prediction, and drug resistance detection tools, halting [Client’s] research would be damaging to disease prevention and public health systems. It is, therefore, within the interests of the US to allow [Client’s] research to continue.”

We congratulate this client on their EB-1A approval. Through NAILG, we are honored to support distinguished researchers like them whose exceptional expertise enhances the scientific and medical leadership of the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.